University of California San Francisco

Leslie Wilson, PhD

Leslie Wilson, PhD
Leslie Wilson, PhD

Professor, Medicine and Clinical Pharmacy

Address

490 Illinois Street, #32F
San Francisco, CA 94158
United States

Email: [email protected]
Phone: 415-990-1012
Fax: 415-502-0792

ORCID: 0000-0002-3305-8730

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 89
  1. The design and rationale of the Biomarkers for Evaluating Spine Treatments trial: a sequential multiple assignment randomized trial.
    Mauck MC, Barth KS, Bell KM, Brooks AK, Chadwick AL, Gunn CA, Hurley RW, Ivanova A, Piva SR, Schneider MJ, Bailey JF, Bagaason S, Batorsky A, Borckardt JJ, Bowden AE, Carey TS, Castellanos J, Chen L, Chidgey B, Dalton D, Dufour JS, Fields AJ, Fritz JM, Goolsby RW, Greco CM, Harris RE, Harte S, Hassett AL, Hoffmeyer A, Jones Berkeley S, Kaplan C, Kidwell KM, Knapik GG, Kosorok MR, Kurillo G, Lobo R, Lotz JC, Mackey S, Mageswaran P, Majumdar S, Mao J, Marras WS, McCumber M, McLean SA, Mehling W, Mitchell UH, Napadow VJ, O'Neill C, Patel KV, Peltier S, Psioda M, Rowland B, Rundell SD, Schrepf A, Sperger J, Vo N, Wallace MS, Wasan AD, Weaver TE, Weber KA, Williams DA, Wilson L, Zeidan F, Zhao B, Anstrom KJ, Clauw DJ, Sowa GA| | PubMed
  2. Baseline characteristics of participants in the Biomarkers for Evaluating Spine Treatments clinical trial: a sequential multiple assignment randomized trial for chronic low back pain†.
    Rowland B, Barth KS, Bell KM, Brooks AK, Chadwick AL, Cleven A, Hurley RW, Mackey S, Patel KV, Piva SR, Schneider MJ, Al-Kadhi F, Asante-Nketiah B, Bagaason S, Batorsky A, Borckardt JJ, Bowden AE, Carey TS, Castellanos J, Chen L, Chidgey B, Dalton D, Dufour JS, Eberting JL, Eller SM, Fields AJ, Fritz JM, Fu A, Ghulamhussain I, Goolsby RW, Greco CM, Grim S, Gunn CA, Hanes L, Harris RE, Harte SE, Hassett AL, Helton K, Hoffmeyer A, Ivanova A, Jones Berkeley S, Kaplan C, Kidwell KM, Knapik GG, Kosorok MR, Kurillo G, Li D, Lobo R, Long J, Lotz JC, Mageswaran P, Majumdar S, Mao J, Marras WS, McCracken LM, McCumber M, McLean SA, McMillan M, Mehling W, Mendoza R, Mitchell UH, Napadow V, O'Neill C, Pearson S, Peltier S, Rundell SD, Ryser S, Schrepf A, Schulze E, Sperger J, Vo N, Wallace MS, Wampler AM, Wasan AD, Weaver TE, Weber KA, Wilcox L, Williams DA, Wilson L, Woo JE, Zeidan F, Zhao B, Zhou B, Anstrom KJ, Clauw DJ, Sowa GA, Mauck MC| | PubMed
  3. Preferences for Attachment Devices for Individuals with Lower-Limb Loss: A Discrete-Choice Study to Inform Regulatory Decisions.
    Wilson L, Garibaldi M, Vargas R, Timmerman M| | PubMed
  4. Outcomes and Preferences for Decision-Making for Upper Limb Prosthetic Care: The Patient Journey: A Scoping Literature Review.
    Wilson L, Gutin M, Banh T, Gress E, Castleberry T, Asatkar S, Tahir P, Douglas MP, Wurdeman SR| | PubMed
  5. National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling.
    Badal K, Staib J, Tice JA, Kim MO, Eklund M, Wilson L, Dacosta Byfield S, Catlett K, Maffey L, Soonavala R, Shieh Y, Esserman LJ| | PubMed
  6. Diabetes disparities in diabetes health care access and outcomes during the COVID-19 pandemic in the United States.
    Zhong L, Ma Y, Ionova Y, Bhatt A, Vargas R, Banh T, Wilson L| | PubMed
  7. The Comparison of Cost-Effectiveness Between Magnetic Resonance Spectroscopy and Provocative Discography in the Identification of Chronic Low Back Pain Surgery Candidates.
    Wilson L, Beall DP, Eastlack RK, Berven S, Lotz JC| | PubMed
  8. The opioid public health crisis in Texas: Characterizing real-world healthcare resource utilization and economic burden in different clinical settings.
    Zhong L, Smith ML, Lyu N, Davlasheridze M, Alonzo J, Lee S, Wilson L, Ory MG| | PubMed
  9. Preferences for risks and benefits of treatment outcomes for chronic low back pain: Choice-based conjoint measure development and discrete choice experiment.
    Wilson L, Denham A, Ionova Y, O'Neill C, Greco CM, Hassett AL, Hanmer J, Shaikh S, Wolf M, Berven S, Williams D, Ma Y, Lotz J, Zheng P| | PubMed
  10. Patient Preference Trade-offs for Next-Generation Kidney Replacement Therapies.
    Wilson L, Gress AF, Frassetto L, Sarathy H, Gress EA, Fissell WH, Roy S| | PubMed
  11. CAPER: patient preferences to inform nonsurgical treatment of chronic low back pain: a discrete-choice experiment.
    Wilson L, Zheng P, Ionova Y, Denham A, Yoo C, Ma Y, Greco CM, Hanmer J, Williams DA, Hassett AL, Scheffler AW, Valone F, Mehling W, Berven S, Lotz J, O'Neill C| | PubMed
  12. Prosthesis preferences for those with upper limb loss: Discrete choice study of PULLTY® for use in regulatory decisions.
    Wilson L, Dohan D, Garibaldi M, Szeto D, Timmerman M, Matheny J| | PubMed
  13. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
    Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L| | PubMed
  14. Preferences for Risks and Benefits of Islet Cell Transplantation for Persons With Type 1 Diabetes With History of Episodes of Severe Hypoglycemia: A Discrete-Choice Experiment to Inform Regulatory Decisions.
    Wilson L, Kwok T, Ma Y, Wong J, Ho M, Ionova Y, McGrath M, Mueller MM, Gitelman SE, Irony T| | PubMed
  15. Analyzing excipient-related adverse events in antiseizure drug formulations.
    Ionova Y, Peterson T, Wilson L| | PubMed
  16. Cost-Effectiveness Analysis of Atezolizumab Versus Durvalumab as First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer in the USA.
    Ionova Y, Vuong W, Sandoval O, Fong J, Vu V, Zhong L, Wilson L| | PubMed
  17. A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma.
    Chan A, Dang C, Wisniewski J, Weng X, Hynson E, Zhong L, Wilson L| | PubMed
  18. Cost-effectiveness of adding daratumumab or bortezomib to lenalidomide plus dexamethasone for newly diagnosed multiple myeloma.
    Narsipur N, Bulla S, Yoo C, Do B, Tran K, Gu D, Zhong L, Wilson L| | PubMed
  19. Cost-Effectiveness of Adding Ribociclib to Endocrine Therapy for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer Among Premenopausal or Perimenopausal Women.
    Jeong E, Wang C, Wilson L, Zhong L| | PubMed
  20. Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy.
    Best RL, LaPointe NE, Azarenko O, Miller H, Genualdi C, Chih S, Shen BQ, Jordan MA, Wilson L, Feinstein SC, Stagg NJ| | PubMed
  21. Higher-Calorie Refeeding in Anorexia Nervosa: 1-Year Outcomes From a Randomized Controlled Trial.
    Golden NH, Cheng J, Kapphahn CJ, Buckelew SM, Machen VI, Kreiter A, Accurso EC, Adams SH, Le Grange D, Moscicki AB, Sy AF, Wilson L, Garber AK| | PubMed
  22. Cost-Effectiveness Analysis of Hepatic Arterial Infusion of FOLFOX Combined Sorafenib for Advanced Hepatocellular Carcinoma With Portal Vein Invasion.
    Li M, Lin S, Wilson L, Huang P, Wang H, Lai S, Dong L, Xu X, Weng X| | PubMed
  23. Cost-effectiveness of ribociclib plus endocrine therapy versus placebo plus endocrine therapy in HR-positive, HER2-negative breast cancer.
    Le V, Zhong L, Narsipur N, Hays E, Tran DK, Rosario K, Wilson L| | PubMed
  24. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
    Berry DL, Hong F, Blonquist TM, Halpenny B, Xiong N, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M| | PubMed
  25. Short-term Outcomes of the Study of Refeeding to Optimize Inpatient Gains for Patients With Anorexia Nervosa: A Multicenter Randomized Clinical Trial.
    Garber AK, Cheng J, Accurso EC, Adams SH, Buckelew SM, Kapphahn CJ, Kreiter A, Le Grange D, Machen VI, Moscicki AB, Sy A, Wilson L, Golden NH| | PubMed
  26. Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness Analysis.
    Grizzle AJ, Wilson L, Nix DE, Galgiani JN| | PubMed
  27. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y, Wilson L| | PubMed
  28. The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer.
    Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR| | PubMed
  29. A cost-effectiveness analysis comparing a conventional mechanical needle to a radiofrequency device for transseptal punctures.
    Sanchez JM, Shah R, Kouassi Y, Chronowic M, Wilson L, Marcus GM| | PubMed
  30. Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop.
    Benz HL, Lee TJ, Tsai JH, Bridges JFP, Eggers S, Moncur M, Shaya FT, Shoulson I, Spatz ES, Wilson L, Saha A| | PubMed
  31. The Patient Perspective: Putting the Patient at the Center of the Translational Innovation Process.
    Wilson L, Lin L, Singh K| | PubMed
  32. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
    Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS| | PubMed
  33. Weight Loss and Illness Severity in Adolescents With Atypical Anorexia Nervosa.
    Garber AK, Cheng J, Accurso EC, Adams SH, Buckelew SM, Kapphahn CJ, Kreiter A, Le Grange D, Machen VI, Moscicki AB, Saffran K, Sy AF, Wilson L, Golden NH| | PubMed
  34. Minireview - Microtubules and Tubulin Oligomers: Shape Transitions and Assembly by Intrinsically Disordered Protein Tau and Cationic Biomolecules.
    Safinya CR, Chung PJ, Song C, Li Y, Miller HP, Choi MC, Raviv U, Ewert KK, Wilson L, Feinstein SC| | PubMed
  35. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
    Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR| | PubMed
  36. Utilization, Cost, and Pricing Scheme of Compounded Medications for Public Health System Patients: The California Workers' Compensation System, 2011-2013.
    Lin TK, Shoair OA, Tran D, Wilson L| | PubMed
  37. The costs of dementia subtypes to California Medicare fee-for-service, 2015.
    Chen Y, Wilson L, Kornak J, Dudley RA, Merrilees J, Bonasera SJ, Byrne CM, Lee K, Chiong W, Miller BL, Possin KL| | PubMed
  38. Financial Impact of Alternative Pricing Benchmarks for Physician-Dispensed Drugs in the California Workers' Compensation System.
    Wilson L, Turkistani F, Tran DM, Huang W, Lin TK| | PubMed
  39. The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California.
    Wilson L, Ting J, Lin H, Shah R, MacLean M, Peterson MW, Stockamp N, Libke R, Brown P| | PubMed
  40. Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of endosomal recycling.
    Cimino PJ, Huang L, Du L, Wu Y, Bishop J, Dalsing-Hernandez J, Kotlarczyk K, Gonzales P, Carew J, Nawrocki S, Jordan MA, Wilson L, Lloyd GK, Wirsching HG| | PubMed
  41. Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems.
    Tang J, Zhong L, Paoli C, Paciorek A, Carroll P, Wilson L| | PubMed
  42. Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
    Wilson LS, Blonquist TM, Hong F, Halpenny B, Wolpin S, Chang P, Filson CP, Master VA, Sanda MG, Chien GW, Jones RA, Krupski TL, Berry DL| | PubMed
  43. A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service.
    Zakinova A, Long-Boyle JR, French D, Croci R, Wilson L, Phillips KA, Kroetz DL, Shin J, Tamraz B| | PubMed
  44. Cost-Effectiveness of a Behavioral Psychosocial Treatment Integrated Across Home and School for Pediatric ADHD-Inattentive Type.
    Tran JLA, Sheng R, Beaulieu A, Villodas M, McBurnett K, Pfiffner LJ, Wilson L| | PubMed
  45. A Randomized Controlled Trial of a Text Messaging Intervention to Promote Virologic Suppression and Retention in Care in an Urban Safety-Net Human Immunodeficiency Virus Clinic: The Connect4Care Trial.
    Christopoulos KA, Riley ED, Carrico AW, Tulsky J, Moskowitz JT, Dilworth S, Coffin LS, Wilson L, Johnson-Peretz J, Hilton JF| | PubMed
  46. Use and Costs of Medical Foods and Convenience-Packaged Drugs in the California Workers' Compensation System.
    Lin TK, Wilson L| | PubMed
  47. A gray area for reimbursement: medical foods for non-inborn errors of metabolism.
    Wilson L, Lin TK, Oh A, Cao V| | PubMed
  48. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
    Wilson L, Turkistani FA, Huang W, Tran DM, Lin TK| | PubMed
  49. Maternal depressive symptoms and infant healthcare utilization: The moderating role of prenatal mindfulness.
    Roubinov DS, Felder JN, Vieten C, Coleman-Phox K, Laraia B, Adler N, Wilson L, Epel E, Bush NR| | PubMed
  50. Synchrotron small-angle X-ray scattering and electron microscopy characterization of structures and forces in microtubule/Tau mixtures.
    Chung PJ, Song C, Miller HP, Li Y, Raviv U, Choi MC, Wilson L, Feinstein SC, Safinya CR| | PubMed
  51. Giving Patients a Meaningful Voice in United States Regulatory Decision Making: The Role for Health Preference Research.
    Johnson FR, Beusterien K, Özdemir S, Wilson L| | PubMed
  52. Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
    Berry DL, Hong F, Blonquist TM, Halpenny B, Filson CP, Master VA, Sanda MG, Chang P, Chien GW, Jones RA, Krupski TL, Wolpin S, Wilson L, Hayes JH, Trinh QD, Sokoloff M, Somayaji P| | PubMed
  53. Digital quantification of neurite outgrowth and retraction by phase-contrast microscopy: A tau perspective.
    Cook B, Proctor D, Bromberg R, LaPointe NE, Feinstein SC, Wilson L| | PubMed
  54. Understanding patients' preferences for surgical management of urethral stricture disease.
    Hampson LA, Lin TK, Wilson L, Allen IE, Gaither TW, Breyer BN| | PubMed
  55. Cost Effectiveness of Lenvatinib, Sorafenib and Placebo in Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer.
    Wilson L, Huang W, Chen L, Ting J, Cao V| | PubMed
  56. Cost-Effectiveness of Nivolumab-Ipilimumab Combination Therapy Compared with Monotherapy for First-Line Treatment of Metastatic Melanoma in the United States.
    Oh A, Tran DM, McDowell LC, Keyvani D, Barcelon JA, Merino O, Wilson L| | PubMed
  57. Development of an adaptive, personalized, and scalable dementia care program: Early findings from the Care Ecosystem.
    Possin KL, Merrilees J, Bonasera SJ, Bernstein A, Chiong W, Lee K, Wilson L, Hooper SM, Dulaney S, Braley T, Laohavanich S, Feuer JE, Clark AM, Schaffer MW, Schenk AK, Heunis J, Ong P, Cook KM, Bowhay AD, Gearhart R, Chodos A, Naasan G, Bindman AB, Dohan D, Ritchie C, Miller BL| | PubMed
  58. Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center.
    Wilson L, Lin T, Wang L, Patel T, Tran D, Kim S, Dacey K, Yuen C, Kroon L, Brodowy B, Rodondi K| | PubMed
  59. Use of Conjoint Analysis to Determine Patient Preferences for Surgical Treatment of Urethral Stricture Disease.
    Wilson L, Lin TK, Hampson LA, Oh A, Ting J, Gaither T, Allen I, Breyer BN| | PubMed
  60. Patient-centered Treatment Decisions for Urethral Stricture: Conjoint Analysis Improves Surgical Decision-making.
    Hampson LA, Allen IE, Gaither TW, Lin T, Ting J, Osterberg EC, Wilson L, Breyer BN| | PubMed
  61. Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.
    Sánchez-González G, Figueroa-Lara A, Elizondo-Cano M, Wilson L, Novelo-Garza B, Valiente-Banuet L, Ramsey JM| | PubMed
  62. Direct Costs of Acute Recurrent and Chronic Pancreatitis in Children in the INSPPIRE Registry.
    Ting J, Wilson L, Schwarzenberg SJ, Himes R, Barth B, Bellin MD, Durie PR, Fishman DS, Freedman SD, Gariepy CE, Giefer MJ, Gonska T, Husain SZ, Kumar S, Morinville VD, Lowe ME, Ooi CY, Pohl JF, Troendle D, Usatin D, Werlin SL, Wilschanski M, Heyman MB, Uc A| | PubMed
  63. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
    Ting J, Tien Ho P, Xiang P, Sugay A, Abdel-Sattar M, Wilson L| | PubMed
  64. Targeted Therapies Compared to Dacarbazine for Treatment of BRAF(V600E) Metastatic Melanoma: A Cost-Effectiveness Analysis.
    Shih V, Ten Ham RM, Bui CT, Tran DN, Ting J, Wilson L| | PubMed
  65. Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma.
    Li Y, Bare LA, Bender RA, Sninsky JJ, Wilson LS, Devlin JJ, Waldman FM| | PubMed
  66. The cost of surveillance after urethroplasty.
    Zaid UB, Hawkins M, Wilson L, Ting J, Harris C, Alwaal A, Zhao LC, Morey AF, Breyer BN| | PubMed
  67. Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis.
    Wilson LS, Loucks A, Gipson G, Zhong L, Bui C, Miller E, Owen M, Pelletier D, Goodin D, Waubant E, McCulloch CE| | PubMed
  68. A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial.
    Christopoulos KA, Riley ED, Tulsky J, Carrico AW, Moskowitz JT, Wilson L, Coffin LS, Falahati V, Akerley J, Hilton JF| | PubMed
  69. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
    Wilson L, Loucks A, Bui C, Gipson G, Zhong L, Schwartzburg A, Crabtree E, Goodin D, Waubant E, McCulloch C| | PubMed
  70. New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?
    Wilson L, Tang J, Zhong L, Balani G, Gipson G, Xiang P, Yu D, Srinivas S| | PubMed
  71. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments.
    Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C| | PubMed
  72. Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.
    Zhong L, Pon V, Srinivas S, Nguyen N, Frear M, Kwon S, Gong C, Malmstrom R, Wilson L| | PubMed
  73. Decision support by telephone: randomized controlled trial in a rural community setting.
    Belkora J, Stupar L, O'Donnell S, Loucks A, Moore D, Jupiter C, Johnson N, Wilson L| | PubMed
  74. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.
    Wilson LS, Pregenzer M, Basu R, Bertenthal D, Torres J, Asgari M, Chren MM| | PubMed
  75. The effect of prophylaxis on pediatric HIV costs.
    Wilson LS, Hensic L, Paoli CJ, Basu R, Christenson M, Moskowitz JT, Wara D| | PubMed
  76. Pediatric HIV costs across three treatment eras from 1986 to 2007.
    Wilson LS, Basu R, Christenson M, Hensic L, Paoli C, Wara D, Moskowitz JT| | PubMed
  77. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks.
    Wilson LS, Ramsey JM, Koplowicz YB, Valiente-Banuet L, Motter C, Bertozzi SM, Tobler LH| | PubMed
  78. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
    Gitlin M, Wilson L| | PubMed
  79. Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial.
    Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J, Acquah J, Burns B, Chapman J, Hecht FM| | PubMed
  80. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR| | PubMed
  81. Caregiving time in sickle cell disease: psychological effects in maternal caregivers.
    Moskowitz JT, Butensky E, Harmatz P, Vichinsky E, Heyman MB, Acree M, Wrubel J, Wilson L, Folkman S| | PubMed
  82. Cost-effectiveness of Chagas disease interventions in latin america and the Caribbean: Markov models.
    Wilson LS, Strosberg AM, Barrio K| | PubMed
  83. New workers' compensation legislation: expected pharmaceutical cost savings.
    Wilson L, Gitlin M| | PubMed
  84. The economic burden of home care for children with HIV and other chronic illnesses.
    Wilson LS, Moskowitz JT, Acree M, Heyman MB, Harmatz P, Ferrando SJ, Folkman S| | PubMed
  85. Economic and psychologic costs for maternal caregivers of gastrostomy-dependent children.
    Heyman MB, Harmatz P, Acree M, Wilson L, Moskowitz JT, Ferrando S, Folkman S| | PubMed
  86. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
    Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA| | PubMed
  87. Cost-effectiveness of intraoperative facial nerve monitoring in middle ear or mastoid surgery.
    Wilson L, Lin E, Lalwani A| | PubMed
  88. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.
    Reyes CM, Allen BA, Terdiman JP, Wilson LS| | PubMed
  89. The direct cost and incidence of systemic fungal infections.
    Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J| | PubMed